Clinical psychologist Talia Zaider talked about the emotional distress some men experience as a result of sexual dysfunction related to prostate cancer treatment.
Medical oncologist Leonard Saltz, epidemiologist Peter Bach, and Physician-in-Chief Robert Wittes authored an opinion piece on Memorial Sloan-Kettering’s decision not to carry a new colorectal cancer drug due to its cost. They argue that the drug is no better than other, less expensive options.
Good Morning America co-host Robin Roberts said good-bye to her Memorial Sloan-Kettering inpatient treatment team, after being hospitalized for several weeks and receiving a stem cell transplant for the treatment of myelodysplastic syndrome. Chief of Memorial Sloan-Kettering’s Adult Bone Marrow Transplant ServiceSergio Giralt is directing Ms. Roberts’s care.
Radiologist Carol Lee spoke about the benefits and risks of 3-D mammography, or tomosynthesis. Dr. Lee also discussed the technology in the Washington Post and the Morning Call.
Director of Memorial Sloan-Kettering's Adult Long-Term Follow-Up ProgramKevin Oeffinger discussed a study that found that more young adult cancer survivors are likely to go without medical care because of cost than peers who have not had cancer.
Medical oncologist Clifford Hudis discussed the latest research on the link between obesity and cancer, and dietitian Cara Anselmo discussed ways to maintain a healthy weight during and after cancer treatment, for WABC-TV’s annual breast cancer special.
Researchers led by chemist Samuel Danishefsky reported that erythropoietin (also known as EPO), the hormone that controls the production of red blood cells, had been synthesized for the first time.
Surgical oncologist Deborah Capko was one of several experts consulted to rank the greatest risk factors for cancer. Topping the list were smoking, age, and UV radiation from the sun.
